Creative Bloq on MSN9d
Umbro caught in never ending logo design dispute
Sports brand Umbro is in an ongoing design dispute with footwear brand Dream Pairs over alleged logo infringement. It was ...
Yahoo Finance2d
GlucoTrack, Inc. (GCTK)
Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with ...
GlucoTrack to present first-in-human study for CBGM at 2025 conference on ATTD
people with diabetes announced that safety and performance data from its first-in-human trial of its long-term continuous blood glucose ...
Nasdaq9d
Glucotrack, Inc. Announces First-in-Human Trial Data for Continuous Blood Glucose Monitoring System to be Presented at 2025 ATTD Conference
RUTHERFORD, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for ...
Are you artistic? Delray Beach asking local artists to design new Old School Square logo
The Delray Beach cultural arts center, now under the city's ownership, launched its 'A Legacy Through Local Art' initiative ...
WOOD-TV9d
Safety and performance data from direct blood glucose measurement technology to be featured at international diabetes technology conference
RUTHERFORD, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for ...
Finanznachrichten25d
Glucotrack, Inc.: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the successful ...
Nasdaq9d
Glucotrack To Present First-In-Human Results Of Continuous Blood Glucose Monitor At ATTD 2025
(RTTNews) - Glucotrack, Inc. (GCTK), Wednesday, announced the results from its first-in-human trial of its continuous blood glucose monitoring or CBGM system, which will be presented at the 2025 ...
Investing15d
Glucotrack finalizes equity securities sales
RUTHERFORD, NJ – Glucotrack, Inc. (NASDAQ:GCTK), a medical device company with a market capitalization of $3.54 million, disclosed the completion of several transactions involving unregistered sales ...